Health and Healthcare

Acadia Pharmaceuticals : ACAD

All Acadia Pharmaceuticals Articles

77 Articles

Lee Jackson | Jul 2, 2014 at 9:00 AM EDT

The Path to FDA Approval Could Launch Seven Biotech Stocks Much Higher

A new report from the analysts at Cowen shows that, on average, biotech stocks gained 84% in the 12 months…

Paul Ausick | Jun 10, 2013 at 4:06 PM EDT

Closing Bell for Monday on Wall Street: Markets Open Higher, but Slip Later

U.S. equity markets opened higher this morning following some mixed economic data released in China. The country’s CPI rose less…

Paul Ausick | Apr 11, 2013 at 4:29 PM EDT

Market Close: Big Winners & Losers for April 11, 2013 (ACAD, RAD, MEA, RDHL, INOC, NTIC, LEDS, DRTX, FTNT, GNVC)

thinkstockHere are today’s five biggest gaining stocks at closing: ACADIA Pharmaceuticals inc. (NASDAQ: ACAD) is up 64.4% at $13.10. Rite…

Paul Ausick | Apr 11, 2013 at 4:05 PM EDT

24/7 Wall St. Closing Bell — April 11, 2013: Markets Mostly Hold Early Gains (MSFT, ADBE, SLB, KRFT, UA, ADTN, BBBY, NG, PIR, LEDS, CRMB, RAD, ACAD, BBRY, HPQ)

U.S. equity markets opened flat to lower this morning following yesterday’s record-setting session. Economic data was minimal today. In Asia,…

Paul Ausick | Mar 21, 2013 at 4:29 PM EDT

Market Close: Big Winners & Losers for March 21, 2013 (ANAC, ACAD, ENTA, CMT, AFFY, BLDP, GMO, CIMT, AQ, SCHL)

thinkstockHere are today’s five biggest gaining stocks at closing: Anacor Pharmaceuticals Inc. (NASDAQ: ANAC) is up 26% at $4.84. ACADIA…

Paul Ausick | Mar 21, 2013 at 4:04 PM EDT

24/7 Wall St. Closing Bell — March 21, 2013: Markets Slide on Europe Fears (FDX, WSM, YHOO, BKW, HON, ORCL, JBL, TUMI, KBH, LULU, MOV, ROST, MU, NKE, SLW, VRNG, DRI, TIF, AFFY, ACAD)

U.S. equity markets opened lower this morning and trailed slowly downward all day. The situation in Cyprus was unchanged this…

Paul Ausick | Nov 27, 2012 at 4:06 PM EST

24/7 Wall St. Closing Bell — November 27, 2012: Markets Falter Again (SHOO, BRCD, YELP, NOV, CVC, ADT, ADI, GMCR, PVH, AEO, ANN, EXPR, TFM, JASO, MOV, LEDS, RAH, CAG, ACAD, MMR)

U.S. equity markets opened lower again this morning, even following an agreement on the amount and delivery date of another…

247sam | Nov 27, 2012 at 10:28 AM EST

Today’s Market Winners and Losers

The stock market is down Tuesday, with the Dow Jones Industrial Average down 0.24%, the Nasdaq down 0.26% and the…

Jon C. Ogg | Nov 27, 2012 at 8:58 AM EST

ACADIA Rises Exponentially on Phase III Parkinson’s Disease Trial

ThinkstockACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) is proving to be the big winner of the day. In fact, it may be…

Jon C. Ogg | Apr 14, 2010 at 11:31 AM EDT

BioHealth Business Daily (ACAD, AEN, DNDN, EXAS, ITMN, MIPI, OREX, OSIP, RNN, SLXP, VVUS)

We are seeing many news-related movers in today’s edition of the BioHealth Business Daily. ACADIA Pharmaceuticals, Inc. (NASDAQ: ACAD), Adeona…

Douglas A. McIntyre | Jul 8, 2008 at 6:29 AM EDT

Top 10 Pre-Market Analyst Calls (ACAD, ACE, AACC, RATE, GYMB, KIM, MMC, MVL, NCR, WSH)

These aren’t all of the analyst calls out there today, but these are ten of the calls impacting shares early…

Douglas A. McIntyre | Jun 16, 2008 at 3:00 PM EDT

The 52-Week Low Club (PPC)(PBG)(RCL)(GHS)(ACAD)

Pilgrim’s Pride (PPC) Downgraded by Credit Suisse. Down to $15.67 from 52-week high of $41. Pepsi Bottling Group (PBG) Still…

Douglas A. McIntyre | Apr 16, 2008 at 11:18 AM EDT

Biotech Busine$$ Daily (ACAD, AMLN, CVTX, HALO, KOSN, MCU, NVAX, POZN, REGN, SIRT)

If you thought biotech news was getting quiet going into earnings season, think again. Acadia Pharmaceuticals Inc. (ACAD) presents Phase…

Douglas A. McIntyre | Jul 10, 2007 at 6:41 AM EDT

Pre-Market Analyst Calls (July 10, 2007)

ACAD started as Outperform at FBR.ALC started as Outperform at RBC.ARUN started as Buy at Jefferies.ATVI started as Buy at…

Douglas A. McIntyre | Jun 15, 2007 at 5:45 PM EDT

Cramer Speculates in CV Therapeutics (CVTX)

On tonight’s Mad Money on CNBC, Jim Cramer had his normal ‘Speculation Friday’ and talked CV Therapeutics (CVTX) for a…

1 … 3 4 5 6

Acadia Pharmaceuticals : ACAD

All Acadia Pharmaceuticals Articles

The Path to FDA Approval Could Launch Seven Biotech Stocks Much Higher

Closing Bell for Monday on Wall Street: Markets Open Higher, but Slip Later

Market Close: Big Winners & Losers for April 11, 2013 (ACAD, RAD, MEA, RDHL, INOC, NTIC, LEDS, DRTX, FTNT, GNVC)

24/7 Wall St. Closing Bell — April 11, 2013: Markets Mostly Hold Early Gains (MSFT, ADBE, SLB, KRFT, UA, ADTN, BBBY, NG, PIR, LEDS, CRMB, RAD, ACAD, BBRY, HPQ)

Market Close: Big Winners & Losers for March 21, 2013 (ANAC, ACAD, ENTA, CMT, AFFY, BLDP, GMO, CIMT, AQ, SCHL)

24/7 Wall St. Closing Bell — March 21, 2013: Markets Slide on Europe Fears (FDX, WSM, YHOO, BKW, HON, ORCL, JBL, TUMI, KBH, LULU, MOV, ROST, MU, NKE, SLW, VRNG, DRI, TIF, AFFY, ACAD)

24/7 Wall St. Closing Bell — November 27, 2012: Markets Falter Again (SHOO, BRCD, YELP, NOV, CVC, ADT, ADI, GMCR, PVH, AEO, ANN, EXPR, TFM, JASO, MOV, LEDS, RAH, CAG, ACAD, MMR)

Today’s Market Winners and Losers

ACADIA Rises Exponentially on Phase III Parkinson’s Disease Trial

BioHealth Business Daily (ACAD, AEN, DNDN, EXAS, ITMN, MIPI, OREX, OSIP, RNN, SLXP, VVUS)

Top 10 Pre-Market Analyst Calls (ACAD, ACE, AACC, RATE, GYMB, KIM, MMC, MVL, NCR, WSH)

The 52-Week Low Club (PPC)(PBG)(RCL)(GHS)(ACAD)

Biotech Busine$$ Daily (ACAD, AMLN, CVTX, HALO, KOSN, MCU, NVAX, POZN, REGN, SIRT)

Pre-Market Analyst Calls (July 10, 2007)

Cramer Speculates in CV Therapeutics (CVTX)

‘Convert $100,000 a Year to Get Them to the Top of the 22%’: The Roth Plan for a Couple With $2.3M in 401(k)s

UFO ETF Faces a Critical Test: Can Pre-Profit Space Stocks Deliver on $1.85B Backlog

Warren Buffett’s Parting Gift to Investors Is Crushing the Market 6 Months Later

'Convert $100,000 a Year to Get Them to the Top of the 22%': The Roth Plan for a Couple With $2.3M in 401(k)s

College-Educated Families Earned $242,200 While Others Made $42,200, Here's Why the Gap Widened

‘Convert $100,000 a Year to Get Them to the Top of the 22%’: The Roth Plan for a Couple With $2.3M in 401(k)s

UFO ETF Faces a Critical Test: Can Pre-Profit Space Stocks Deliver on $1.85B Backlog

Acadia Pharmaceuticals : ACAD

All Acadia Pharmaceuticals Articles

The Path to FDA Approval Could Launch Seven Biotech Stocks Much Higher

Closing Bell for Monday on Wall Street: Markets Open Higher, but Slip Later

Market Close: Big Winners & Losers for April 11, 2013 (ACAD, RAD, MEA, RDHL, INOC, NTIC, LEDS, DRTX, FTNT, GNVC)

24/7 Wall St. Closing Bell — April 11, 2013: Markets Mostly Hold Early Gains (MSFT, ADBE, SLB, KRFT, UA, ADTN, BBBY, NG, PIR, LEDS, CRMB, RAD, ACAD, BBRY, HPQ)

Market Close: Big Winners & Losers for March 21, 2013 (ANAC, ACAD, ENTA, CMT, AFFY, BLDP, GMO, CIMT, AQ, SCHL)

24/7 Wall St. Closing Bell — March 21, 2013: Markets Slide on Europe Fears (FDX, WSM, YHOO, BKW, HON, ORCL, JBL, TUMI, KBH, LULU, MOV, ROST, MU, NKE, SLW, VRNG, DRI, TIF, AFFY, ACAD)

24/7 Wall St. Closing Bell — November 27, 2012: Markets Falter Again (SHOO, BRCD, YELP, NOV, CVC, ADT, ADI, GMCR, PVH, AEO, ANN, EXPR, TFM, JASO, MOV, LEDS, RAH, CAG, ACAD, MMR)

Today’s Market Winners and Losers

ACADIA Rises Exponentially on Phase III Parkinson’s Disease Trial

BioHealth Business Daily (ACAD, AEN, DNDN, EXAS, ITMN, MIPI, OREX, OSIP, RNN, SLXP, VVUS)

Top 10 Pre-Market Analyst Calls (ACAD, ACE, AACC, RATE, GYMB, KIM, MMC, MVL, NCR, WSH)

The 52-Week Low Club (PPC)(PBG)(RCL)(GHS)(ACAD)

Biotech Busine$$ Daily (ACAD, AMLN, CVTX, HALO, KOSN, MCU, NVAX, POZN, REGN, SIRT)

Pre-Market Analyst Calls (July 10, 2007)

Cramer Speculates in CV Therapeutics (CVTX)

‘Convert $100,000 a Year to Get Them to the Top of the 22%’: The Roth Plan for a Couple With $2.3M in 401(k)s

UFO ETF Faces a Critical Test: Can Pre-Profit Space Stocks Deliver on $1.85B Backlog

Warren Buffett’s Parting Gift to Investors Is Crushing the Market 6 Months Later

Featured Reads

'Convert $100,000 a Year to Get Them to the Top of the 22%': The Roth Plan for a Couple With $2.3M in 401(k)s

College-Educated Families Earned $242,200 While Others Made $42,200, Here's Why the Gap Widened